Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.55 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.55 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 5/20 | 0.44 |
| ▸ | CTSD | P07339 | 2/20 | 0.44 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 2/20 | 0.42 |
| ▸ | GABRD | O14764 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20542530 | 1.00 | DPP4 (0.55) | DPP4DPP8DPP9PTGS1GSTK1 | |
| SCHEMBL18339144 | 0.91 | DPP4 (0.52) | DPP4DPP8DPP9PTGS1GSTK1 | |
| SCHEMBL29538909 | 0.90 | DPP4 (0.54) | DPP4DPP8DPP9PTGS1GSTK1 | |
| SCHEMBL29870202 | 0.89 | BACE1 (0.49) | DPP4DPP8DPP9PTGS1GSTK1 | |
| SCHEMBL24591966 | 0.84 | DPP4 (0.58) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL29531781 | 0.84 | DPP4 (0.58) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL14359921 | 0.84 | DPP4 (0.58) | DPP4DPP8DPP9PTGS1GSTK1 | |
| SCHEMBL30052468 | 0.84 | FNTA (0.43) | DPP4DPP8DPP9PTGS1GSTK1 | |
| SCHEMBL537127 | 0.84 | DPP4 (0.61) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL537129 | 0.84 | DPP4 (0.61) | DPP4DPP8DPP9BACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302080-A1 | SWEETNESS AND/OR FLAVOR ENHANCER | AJINOMOTO CO., INC. (JP) | 2025-10-02 | — | — | US | claimed |
| EP-4613108-A1 | SWEETNESS AND/OR FLAVOR ENHANCER | AJINOMOTO CO., INC. (JP) | 2025-09-10 | — | — | EP | claimed |
| CN-120152627-A | Sweetness and/or flavor enhancer | 味之素株式会社 | 2025-06-13 | — | — | CN | claimed |
| CN-118897023-B | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2025-03-25 | — | — | CN | claimed |
| EP-4507522-A1 | TASTE MODIFYING COMPOSITIONS AND USES THEREOF | Firmenich SA (CH) | 2025-02-19 | — | — | EP | claimed |
| CN-118897023-A | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2024-11-05 | — | — | CN | claimed |
| WO-2024096132-A1 | SWEETNESS AND/OR FLAVOR ENHANCER | 味の素株式会社 | 2024-05-10 | — | — | WO | claimed |
| US-20240036041-A1 | KOKUMI TASTE ENHANCEMENT AND RELATED SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2024-02-01 | — | — | US | claimed |
| WO-2023247332-A1 | TASTE MODIFYING COMPOSITIONS AND USES THEREOF | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| EP-4211469-A1 | KOKUMI TASTE ENHANCEMENT AND RELATED SCREENING METHODS | Firmenich Incorporated (US) | 2023-07-19 | — | — | EP | claimed |
| EP-3538543-B1 | PROTRANSDUZIN-S - AN ENHANCER OF GENE TRANSFER | PHARIS BIOTEC GMBH (DE) | 2022-06-08 | — | — | EP | claimed |
| WO-2022115837-A1 | KOKUMI TASTE ENHANCEMENT AND RELATED SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2022-06-02 | — | — | WO | claimed |
| WO-2026070371-A1 | ENZYMATIC REACTION COMPOSITION OF COFFEE BEANS OR COFFEE GROUNDS, FERMENTATION COMPOSITION OF COFFEE BEANS OR COFFEE GROUNDS, METHODS FOR PRODUCING SAME, AND SEASONING COMPOSITION | 株式会社ファーメンステーション | 2026-04-02 | — | — | WO | disclosed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | disclosed |
| EP-4666864-A1 | METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING FOOD | AJINOMOTO CO., INC. (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-20170119032-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED | 2017-05-04 | — | — | US | disclosed |
| US-20170096418-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | FIRMENICH INCORPORATED | 2017-04-06 | — | — | US | disclosed |
| US-20170087199-A1 | COMPOSITIONS FOR DELIVERING A COOLING SENSATION | SENOMYX INC (US) | 2017-03-30 | — | — | US | disclosed |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | SENOMYX INC (US) | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119032-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | DPP4 743/4885DPP8 1035/4885DPP9 924/4885 |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | TAS2R5, TAS1R1, TAS2R1 | DPP4 2533/4885DPP8 2465/4885DPP9 2106/4885 |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | DPP4 1133/4885DPP8 2274/4885DPP9 2058/4885 |
| US-20170087199-A1 | COMPOSITIONS FOR DELIVERING A COOLING SENSATION | TRPA1, PDE6G, PDE6D | DPP4 1291/4885DPP8 1545/4885DPP9 897/4885 |
| US-20170096418-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | TRPM8, TRPM6, TRPM4 | DPP4 3386/4885DPP8 322/4885DPP9 2861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.